For CVD, MMP-9 can play a direct role as a biomarker of plaque vulnerability, can be elevated in patients diagnosed with angina or myocardial infarction, is associated with cardiovascular risk factors before the onset of the disease, and is upregulated by pro-inflammatory cytokines, suggesting its impact on the inflammatory process [81]. The gene discussed is MMP9; the disease is angina pectoris.